MedSwitcher
Head-to-Head Comparison

Foundayo vs Wegovy: Which GLP-1 Is Right for You?

Foundayo and Wegovy are both GLP-1 medications approved for weight loss, but they work differently, cost differently, and fit different lifestyles. Foundayo (orforglipron) is Eli Lilly's new daily pill — no food restrictions, no injections. Wegovy (semaglutide) is available as a weekly injection or daily pill (with fasting requirements). Here's how they compare on everything that matters.

Updated April 20268 min readBased on clinical trial data
Quick Comparison
CategoryFoundayoWegovy
FormDaily pill (no food restrictions)Weekly injection or daily pill (30-min fasting)
Weight Loss (max dose)11.2% ITT / 12.4% completers (ATTAIN-1, 17.2mg, 72 weeks)~15% ITT / ~17% completers injectable (STEP 1)
Self-Pay Cost$149-349/mo (dose-dependent)$1,349/mo injectable / $149/mo pill (lower doses)
With Savings Card$25/mo$25/mo
Medicare$50/mo (est. July 2026)Varies by plan
Food RestrictionsNoneNone (injection) / 30-min fast (pill)
Injection RequiredNoYes (injectable) / No (pill)
Nausea Rate~33.7% (ATTAIN-1)~44% (STEP, injectable)
Drug ClassNon-peptide small molecule GLP-1 agonistGLP-1 full agonist
Dosing FrequencyOnce dailyOnce weekly (injection) / once daily (pill)
FDA ApprovalApril 2026June 2021 (injectable) / Dec 2025 (pill)
Safety Track RecordPhase 3 trials + recent approval5+ years of real-world data
Foundayo advantage Wegovy advantage Tie

Choose your next step

Build a personalized switch plan first, or jump to treatment options if you already know which medication you want to discuss with a prescriber.

Get comparison and pricing alerts by email

Calculate Your Switch Plan

Get a personalized dose mapping, cost comparison, and timeline

Open the Calculator →

Ready to act? Oral GLP-1 options from $99/mo

MEDVi offers GLP-1 tablets and injectables — a licensed provider helps you choose.

See Oral GLP-1 Options

Weight Loss: How Do They Compare?

Wegovy injectable wins on raw efficacy. In the STEP 1 trial, Wegovy (semaglutide 2.4mg injection) showed approximately 15% body weight loss (ITT/treatment regimen) to 17% (completers) over 68 weeks. That's the gold standard for single-agent GLP-1 weight loss.

Foundayo is competitive but not quite as powerful. In ATTAIN-1, the highest approved dose (17.2mg) showed 11.2% weight loss (ITT/treatment regimen) to 12.4% (completers) over 72 weeks. Note: Side effect data from ATTAIN-1 comes from the 36mg trial dose (higher than approved doses), so real-world side effect rates at approved doses may be lower.

Wegovy pill vs Foundayo is closer. Oral semaglutide shows somewhat lower efficacy than injectable Wegovy (the oral bioavailability is only ~1%). When comparing pills to pills, Foundayo and oral Wegovy are in a similar range.

Bottom line: If maximum weight loss is your top priority and you don't mind injections, Wegovy injectable is the stronger drug. If you want a pill, Foundayo and oral Wegovy deliver similar results, but Foundayo wins on convenience (no fasting).

Cost Comparison

Cost is where Foundayo shines — see our full Foundayo cost and pricing guide for details:

  • Foundayo self-pay: $149/month (starting dose) to $349/month (highest dose) via LillyDirect
  • Wegovy injectable: ~$1,349/month list price
  • Wegovy pill: $149/month for 1.5mg and 4mg doses. Higher dose pricing not yet publicly set at self-pay level.

With manufacturer savings cards, both can drop to $25/month for commercially insured patients. But for the ~16 million Americans without GLP-1 coverage, the self-pay price is what matters.

Key insight: At lower/middle doses, Foundayo is significantly cheaper. At the highest dose, Wegovy pill ($299) actually undercuts Foundayo ($349). But Foundayo starts at just $149, making it the most affordable way to get started on a GLP-1.

Convenience & Lifestyle

Foundayo wins decisively on convenience:

  • Take any time of day — morning, noon, or night
  • With or without food and water — no restrictions
  • No injection, no needles, no cold storage
  • Easy to travel with — no sharps container needed

Wegovy pill requires strict fasting: You must take it on an empty stomach with a small sip of water, then wait 30 minutes before eating, drinking, or taking other medications. For many people, this is a significant daily inconvenience.

Wegovy injection: Once weekly is convenient scheduling-wise, but requires injection, cold storage, and sharps disposal. Some people develop injection fatigue over months or years.

Side Effects Comparison

Both medications cause GI side effects — that's the nature of GLP-1s. But the rates differ (see our Foundayo side effects week-by-week guide for what to expect):

Foundayo (from ATTAIN-1 at 36mg highest trial dose):

  • Nausea: 33.7%
  • Constipation: 25.4%
  • Diarrhea: 23.1%
  • Vomiting: 24.0%
  • Dyspepsia: 14.1%
  • Hair loss: ~4-5%
  • Discontinuation due to AEs: 10.3%

Wegovy injectable (from STEP trials):

  • Nausea: ~44%
  • Diarrhea: ~30%
  • Vomiting: ~24%
  • Constipation: ~24%
  • Injection site reactions: ~6%

Foundayo has somewhat lower GI side effect rates than Wegovy injectable. As a non-peptide small molecule GLP-1 receptor agonist, orforglipron may produce a different side effect profile compared to semaglutide's peptide-based full agonism. However, direct comparison is difficult because the trials had different designs and patient populations.

Who Should Choose Which?

Choose Foundayo if:

  • You want a pill with no food/water restrictions
  • You're price-sensitive (starting at $149/mo self-pay)
  • You've had bad GI side effects on other GLP-1s
  • You're starting GLP-1 treatment for the first time
  • You're switching from an injectable and want oral convenience

Choose Wegovy if:

  • Maximum weight loss is your top priority
  • You don't mind weekly injections (for the injectable version)
  • You're already on semaglutide and it works for you
  • Your insurance covers Wegovy but not Foundayo
  • You prefer the longer safety track record (5+ years of data)

Already on Zepbound and considering a switch to an oral option? Foundayo also works well for weight maintenance after Zepbound.

The Bottom Line

For most people starting GLP-1 treatment in 2026, Foundayo is the better first choice: it's a pill, it's affordable, it has no food restrictions, and it delivers meaningful weight loss (12.4% at max dose). Wegovy injectable remains the most effective single-agent GLP-1 for pure weight loss, but the gap has narrowed. Your doctor can help you decide based on your specific health situation, insurance coverage, and lifestyle needs.

Get GLP-1 Price Drop Alerts

Join 500+ patients tracking medication prices and availability

Get Free Alerts →

Compare Your Personalized Switch Plan

Switch Calculator
Enter your current medication details to get a personalized switch plan

Frequently Asked Questions

Can I switch from Wegovy to Foundayo?

Yes. You can switch directly with no washout period. Start Foundayo at 0.8mg the day after your last Wegovy dose. See our detailed Wegovy → Foundayo switching guide for dose mapping and timeline.

Is Foundayo the same as Wegovy?

No. Foundayo (orforglipron) and Wegovy (semaglutide) are different molecules from different companies. They're both GLP-1 receptor agonists, but orforglipron is a non-peptide small molecule while semaglutide is a peptide.

Which has fewer side effects?

Foundayo showed lower rates of nausea (33.7% vs 44%), vomiting (24.0% vs 24%), and diarrhea (23.1% vs 30%) compared to Wegovy injectable in their respective clinical trials. However, these weren't head-to-head trials, so direct comparison has limitations.

Which is cheaper without insurance?

Foundayo starts at $149/month (lowest dose), going up to $349/month. Wegovy pill starts at $149/month for lower doses (1.5mg, 4mg). Wegovy injectable is ~$1,349/month. For starting treatment, both Foundayo and Wegovy pill are competitively priced.

Sources

  1. ATTAIN-1 Phase 3 Trial (NCT05869903) — orforglipron weight loss data
  2. STEP Clinical Trial Program — semaglutide (Wegovy) weight loss data
  3. Foundayo (orforglipron) FDA Prescribing Information, Eli Lilly
  4. Wegovy (semaglutide) FDA Prescribing Information, Novo Nordisk
  5. Eli Lilly pricing announcement, April 1, 2026
  6. Business Insider: Foundayo vs Zepbound, Wegovy, Rybelsus comparison, April 2026
Foundayo trust snapshot
Medication
Foundayo
Tracked facts
14
Human verified
0
Last refreshed: 2026-04-07

This page pulls from MedSwitcher's structured medication fact database. Facts are tracked separately from page copy so we can update sources, pricing, and trial details without guessing.

Primary source trail
  • Foundayo Prescribing Information
  • ATTAIN-1 Phase 3 Trial
  • LillyDirect pricing

Want the boring but important details? Read our editorial policy and methodology.

Don't miss price changes

GLP-1 prices are changing — stay ahead

Foundayo prices may increase — get alerts before they do. Track price drops, shortages, and new switching guidance without checking back manually.

  • Price increase warnings before they hit
  • Savings card and coupon alerts
  • New switching guidance and availability updates

No spam. Unsubscribe anytime. We never share your email.

Helpful Articles

Related

This comparison is for informational purposes only and does not constitute medical advice. Clinical trial results referenced here come from different studies with different designs and patient populations — direct comparison between trials has inherent limitations. Always consult your healthcare provider.